Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
06/2003
06/17/2003US6579699 Method for producing fermentative product and stress-resistant microorganism
06/17/2003US6579695 Phosphopantetheinyl transferases and uses thereof
06/17/2003US6579694 Agar medium for the growth of Mycobacterium tuberculosis
06/17/2003US6579693 Comprising nucleic acids encoding human NADPH-cytochrome reductase and human cytochrome; inactivated genes; contacting a chemical compound with an enzyme preparation to determine the metabolites from the degradation of the compound
06/17/2003US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor
06/17/2003US6579674 Administering antisense VA 1 (ava 1) oligodeoxynucleotides with carrier
06/17/2003US6579553 Flavoring materials from filamentous fungi
06/17/2003US6579523 Transplants for myocardial scars
06/17/2003CA2222128C Surface anchoring vector and system for foreign proteins thereof
06/17/2003CA2129820C Dna sequences encoding novel growth/differentiation factors
06/17/2003CA1341432C Variants of plasminogen activators and processes for their production
06/12/2003WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003WO2003048375A1 Hybrid glycosylated products and their production and use
06/12/2003WO2003048367A1 Genetic strain optimization for improving the production of riboflavin
06/12/2003WO2003048364A2 Ovomucoid promoter and methods of use
06/12/2003WO2003048358A1 Adipocyte differentiation-associated gene and protein
06/12/2003WO2003048357A1 Method of activating protein
06/12/2003WO2003048353A1 Polypeptides having protease activity and nucleic acids encoding same
06/12/2003WO2003048351A1 Mutated 6-phosphogluconate dehydrogenase
06/12/2003WO2003048349A2 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048342A2 Liquid yeast compositions
06/12/2003WO2003048329A2 Chromosomal saturation mutagenesis
06/12/2003WO2003048313A2 Cell culture media
06/12/2003WO2003048310A2 Thermus oshimai nucleic acid polymerases
06/12/2003WO2003048309A2 Thermus thermophilus nucleic acid polymerases
06/12/2003WO2003048308A2 Thermus brockianus nucleic acid polymerases
06/12/2003WO2003048307A2 Thermus igniterrae nucleic acid polymerases
06/12/2003WO2003048306A2 Polycistronic expression of antibodies
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048208A2 Expression control using variable intergenic sequences
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003047526A2 Cell adhesion and extracellular matrix proteins
06/12/2003WO2003047507A2 Factor viii c2 domain variants
06/12/2003WO2003047358A1 Cheese flavour ingredient and method of its production
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2002074895A3 Fermentation process including the use of enzymes
06/12/2003WO2002068627A3 Vector constucts
06/12/2003WO2002061088A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
06/12/2003WO2002046435A3 Engineered plasmids and their use for in situ production of genes
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2001083701A8 Light-driven energy generation using proteorhodopsin
06/12/2003WO2000040737A9 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
06/12/2003US20030109694 Novel process
06/12/2003US20030109693 Chondroitin polymerase and DNA encoding the same
06/12/2003US20030109692 Protein G receptors; autoimmune disease, antidiabetic agents, anticancer agents
06/12/2003US20030109689 Using polypeptides; induction immunology response
06/12/2003US20030109685 Schizophrenic, psychological disorders, Parkinson's disease; genetic engineered polypeptide
06/12/2003US20030109684 Antitumor agents; transforming growth factor
06/12/2003US20030109678 Methods and means for regulation of gene expression
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109481 Tumour-cell specific gene expression and its use in cancer therapy
06/12/2003US20030109448 Enhancing cellular uptake and redistributing gene regulating polyamides from the extranuclear areas in eukaryotic cells to the nucleus thereof. The method consists of administering to the eukaryotic cells a molecular trafficking compound
06/12/2003US20030109436 Wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. DNA sequence codes for cells
06/12/2003US20030109430 Immunoassays for human and canine brain natriuretic peptide
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109027 Tumor suppression genes
06/12/2003US20030109026 Genetically modified tumor-targeted bacteria with reduced virulence
06/12/2003US20030109025 Particles containing coated living micro-organisms, and method for producing same
06/12/2003US20030109022 Asp2
06/12/2003US20030109019 In situ polymerase chain reaction
06/12/2003US20030109016 Tumor suppresison gene; anticancer agents
06/12/2003US20030109014 Process for the fermentative preparation of L-amino acids with amplification of the tkt gene
06/12/2003US20030109013 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid
06/12/2003US20030109012 Fermentation enterobacter
06/12/2003US20030109007 Process for producing N-acetylneuraminic acid
06/12/2003US20030109005 Sequence determination; polymerase chain reactions
06/12/2003US20030109004 Culture product; cell transformation; genetic engineering using promoter
06/12/2003US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids
06/12/2003US20030109001 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies
06/12/2003US20030109000 Culture product; binding polypeptides containing activated end groups
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108997 Adjust metabolism of microorganisms; adjust gene expression of protein in Escherichia cells; reduce by-products
06/12/2003US20030108991 Genetic engineering; keratinase fused to nucleic acid
06/12/2003US20030108990 Method for preparing deletion mutants
06/12/2003US20030108988 Thermal tolerant avicelase from acidothermus cellulolyticus
06/12/2003US20030108982 Process for oxidation of steroids and genetically engineered cells used therein
06/12/2003US20030108980 Bioluminescent methods for direct visual detection of environmental compounds
06/12/2003US20030108971 Enzyme
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108953 Truncated egf receptor
06/12/2003US20030108948 Artificial antibody polypeptides
06/12/2003US20030108933 Novel serine-threonine kinase-3
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108923 Blocking gene expression
06/12/2003US20030108912 Liver enriched transcription factor
06/12/2003US20030108908 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
06/12/2003US20030108904 Novel scavenger receptors
06/12/2003US20030108886 Autogene nucleic acids encoding a secretable RNA polymerase
06/12/2003US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
06/12/2003US20030108869 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
06/12/2003US20030108863 Nodavirus-like DNA expression vector and uses therefor
06/12/2003US20030108858 Methods for the simultaneous detection of HCV antigens and HCV antibodies
06/12/2003US20030108642 Penicillium funiculosum strain useful for the production of enzymes
06/12/2003US20030108641 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability
06/12/2003US20030108562 Administering gag protein; vaccines for human immunodeficiency virus
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
1 ... 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 ... 1489